Diabetes, Vol 45, Issue 1 60-66, Copyright © 1996 by American Diabetes Association

ARTICLES

The antihyperglycemic agent englitazone prevents the defect in glucose transport in rats fed a high-fat diet

RW Stevenson, RK McPherson, LM Persson, PE Genereux, AG Swick, J Spitzer, JJ Herbst, KM Andrews, DK Kreutter and EM Gibbs
Department of Metabolic Diseases, Pfizer, Inc., Groton, CT 06340, USA.

The effects of englitazone in male Wistar rats fed a high-fat diet (59% of calories as fat) were compared with control rats fed a high-carbohydrate diet (69% of calories as carbohydrate) (5-15 animals per group). Insulin-stimulated (17 nmol/l) 2-deoxy-D-glucose (2-DG) uptake was inhibited 31% in adipocytes isolated from rats on the high-fat diet for 3 weeks, but englitazone (50 mg/kg for the last 7 days) normalized the response. There was a selective decrease in GLUT4 (54 +/- 5% of high-carbohydrate) in epididymal fat from rats on the high-fat diet for 3 weeks, but englitazone treatment did not reverse the defect in GLUT4 (43 +/- 8% of high-carbohydrate) or increase GLUT1 (81 +/- 12% of high-carbohydrate). Englitazone normalized oral glucose (1 g/kg body wt) intolerance and excessive (210% of high-carbohydrate) liver glycogen deposition (from [14C]glucose) caused by the high-fat diet. The high-fat diet tended to decrease insulin receptor substrate-1 (IRS-1) and phosphatidylinositol-3'-kinase (PI-3-kinase) expression in epididymal fat (26% decrease; P < 0.1). Englitazone did not reverse this decrease in IRS-1 and PI-3-kinase levels in fat from high-fat-fed rats (there was a further 25-30% decrease, P < 0.05), nor did it increase PI-3-kinase activity in 3T3-L1 adipocytes under conditions (48 h incubation) where it stimulated 2-DG uptake sixfold or enhanced insulin-stimulated 2-DG uptake. In summary, englitazone prevented the insulin resistance associated with a high-fat diet, but the mechanism of action does not involve changes in fat or muscle glucose transporter content and may not involve activation of the insulin signaling pathway via PI-3-kinase.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. F. Youngren, J. Paik, and R. J. Barnard Impaired insulin-receptor autophosphorylation is an early defect in fat-fed, insulin-resistant rats J Appl Physiol, November 1, 2001; 91(5): 2240 - 2247. [Abstract] [Full Text] [PDF]

				F. Liu, J.-k. Kim, Y. Li, X.-q. Liu, J. Li, and X. Chen An Extract of Lagerstroemia speciosa L. Has Insulin-Like Glucose Uptake-Stimulatory and Adipocyte Differentiation-Inhibitory Activities in 3T3-L1 Cells J. Nutr., September 1, 2001; 131(9): 2242 - 2247. [Abstract] [Full Text] [PDF]

				J. R. Zierath, J. W. Ryder, T. Doebber, J. Woods, M. Wu, J. Ventre, Z. Li, C. McCrary, J. Berger, B. Zhang, et al. Role of Skeletal Muscle in Thiazolidinedione Insulin Sensitizer (PPAR{gamma} Agonist) Action Endocrinology, December 1, 1998; 139(12): 5034 - 5041. [Abstract] [Full Text] [PDF]

				P. A. Hansen, D. H. Han, B. A. Marshall, L. A. Nolte, M. M. Chen, M. Mueckler, and J. O. Holloszy A High Fat Diet Impairs Stimulation of Glucose Transport in Muscle. FUNCTIONAL EVALUATION OF POTENTIAL MECHANISMS J. Biol. Chem., October 2, 1998; 273(40): 26157 - 26163. [Abstract] [Full Text] [PDF]

				J. J. Wilkes, A. Bonen, and R. C. Bell A modified high-fat diet induces insulin resistance in rat skeletal muscle but not adipocytes Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E679 - E686. [Abstract] [Full Text] [PDF]

				K. S. Park, T. P. Ciaraldi, L. Abrams-Carter, S. Mudaliar, S. E. Nikoulina, and R. R. Henry Troglitazone Regulation of Glucose Metabolism in Human Skeletal Muscle Cultures from Obese Type II Diabetic Subjects J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1636 - 1643. [Abstract] [Full Text]